/assets/img/hottest3.png
/assets/img/hottest3.png

/assets/img/reef2.png
/assets/img/red-line.jpg
/assets/img/reef.png
21ьз╕ Cweather-icon
/assets/img/hottest3.png
/assets/img/hottest3.png

/assets/img/reef2.png
/assets/img/red-line.jpg
/assets/img/reef.png

GSK launches once daily, single inhaler-triple therapy for COPD patients

News2022-04-26
22 Views

GSK launches once daily, single inhaler-triple therapy for COPD patients Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is the first once daily single-inhaler triple therapy (SITT) in India for COPD patients.

Latest News from Moneycontrol.com

Read More..
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.


GAM Holding AG is not in negotiations with Terraform Labs to support the Luna stablecoin



/assets/img/Reliance-Law-Firm.png

/assets/img/cw-stocks.png

/assets/img/wysh-jewels.png

/assets/img/Mars-Parachute-2.png

/assets/img/crweworld-podcast.jpg
Sponsored
Also read